| In The News

Continuous Improvement: The Secret to Navigating Early-Phase Drug Development

In this MedCity News article, Mike Mencer, Executive Vice President and General Manager, Early Phase, explains why deploying a robust continuous improvement methodology is especially beneficial in the earliest phases of drug development – ensuring the delivery of high-quality, reliable, timely bioanalytical and clinical data to make informed decisions about either moving on to the next drug development milestone or pivoting to another strategy.

Read the full article here.

Recent In The News

Resources

Our extensive collection of scientific articles and papers